|
09.10-09.15
|
Welcome - Opening
G. Stergiou
|
|
09.15-10.35
|
1st SESSION
|
|
09.15-10.15
|
ROUND TABLE
Common mistakes in antihypertensive drug treatment
Chairmen: T. Mountokalakis, E. Varsamis
- IN DIABETES MELLITUS
M. Elisaf
- IN RENAL DISEASE
D. Vlahakos
- IN HEART DISEASE
D. Papadogiannis
- IN ACUTE CEREBROVASCULAR DISEASE
K. Vemmos
|
|
10.15-10.35
|
Discussion
|
|
10.35-11.40
|
2nd SESSION
|
|
10.35-11.25
|
ROUND TABLE
New techniques for the assessment of large arteries damage:
Application in clinical practice
Chairmen: I. Lekakis, D. Papadogiannis
CHARACTERISTICS OF THE AVAILABLE TECHNIQUES - WHAT DO THE
GUIDELINES RECOMMEND
C. Vlahopoulos
PULSE WAVE VELOCITY AND AORTIC COMPLIANCE
T. Papaioannou
CENTRAL BLOOD PRESSURE - REFLECTED BLOOD PRESSURE WAVES
A. Protogerou
HOW TO APPLY IN CLINICAL PRACTICE
C. Vlahopoulos
|
|
11.25-11.40
|
Discussion
|
|
11.40-12.00
|
Coffee Break
|
|
12.00-13.30
|
3rd SESSION
Three critical questions for clinical practice: Answers from April 2008 data
|
|
12.00-12.30
|
QUESTION - 1
ACE inhibition, angiotensin receptor blockade or their combination?
Results of the only trial designed to answer this question with 25,000 patients
and 4.5 years follow-up
Chairman: N. Karatzas
Data presentation: S. Voyaki
Comments: A. Karagiannis
Discussion
|
|
12.30-13.00
|
QUESTION - 2
Combination of renin-angiotensin system blockers with calcium
channel blockers or diuretics?
Results of the only trial designed to answer this question with 11,500 patients
and 3.5 years follow-up
Chairman: K. Siamopoulos
Data presentation: K. Tsioufis
Comments: A. Efstratopoulos
Discussion
|
|
13.00-13.30
|
QUESTION - 3
Benefit and harm of antihypertensive treatment in patients
older than 80 years:
Results of the only trial designed to answer this question with 3,850 patients and
2 years follow-up
Chairman: K. Vemmos
Data presentation: T. Makris
Comments: E. Varsamis
Discussion
|
|
13.30-14.00
|
Lunch Break
|
|
14.00-15.30
|
4th SESSION
|
|
15.00-16.00
|
ROUND TABLE
2008 Practice Guidelines of the Hellenic Society
for the Study of Hypertension:
Discussion of barriers in their application in clinical practice -
Which barriers are due to hypertension per se, which to the patient and which to
the physicians
Chairmen: G. Stergiou, A. Achimastos
- BLOOD PRESSURE EVALUATION, DIAGNOSTIC PROBLEMS
N. Zakopoulos, I. Avramopoulos
- DETECTION OF HIGH RISK HYPERTENSIVES
K. Tsioufis, E. Varsamis
- ESSENTIAL INVESTIGATION
C. Vlahopoulos, D. Vlahakos
ANTIHYPERTENSIVE DRUG MONOTHERAPY AND COMBINATIONS
A. Karagiannis, E. Andreadis
- DIFFICULT, RESISTANT AND URGENT HYPERTENSION
A. Efstratopoulos, K. Vemmos
- OPTIMAL BLOOD PRESSURE CONTROL AND LONG-TERM COMPLIANCE
T. Makris, D. Papadogiannis
The 4th session will be recorded and published.
|